BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10754491)

  • 1. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer.
    Sierra A; Castellsagué X; Escobedo A; Lloveras B; García-Ramirez M; Moreno A; Fabra A
    Int J Cancer; 2000 Mar; 89(2):142-7. PubMed ID: 10754491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
    Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
    Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.
    Sierra A; Lloveras B; Castellsagué X; Moreno L; García-Ramirez M; Fabra A
    Int J Cancer; 1995 Jan; 60(1):54-60. PubMed ID: 7814152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas.
    Sierra A; Castellsagué X; Coll T; Mañas S; Escobedo A; Moreno A; Fabra A
    Int J Cancer; 1998 Apr; 79(2):103-10. PubMed ID: 9583721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
    Kristek J; Dmitrović B; Kurbel S; Sakić K; Krajinović Z; Blazicević V; Has B; Marjanović K
    Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
    Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
    Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas.
    Sierra A; Castellsague X; Escobedo A; Moreno A; Drudis T; Fabra A
    Breast Cancer Res Treat; 1999 Mar; 54(1):39-45. PubMed ID: 10369079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
    Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.
    Gonidi M; Athanassiadou AM; Patsouris E; Tsipis A; Dimopoulos S; Kyriakidou V; Chelidonis G; Athanassiadou P
    Pathol Res Pract; 2011 Jun; 207(6):377-82. PubMed ID: 21621926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
    Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, BCL-2, hormone receptors and tumor proliferation.
    Pillai MR; Kesari AL; Chellam VG; Madhavan J; Nair P; Nair MK
    Pathol Res Pract; 1998; 194(8):549-57. PubMed ID: 9779489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 1 aneusomy with 1p36 under-representation is related to histologic grade, DNA aneuploidy, high c-erb B-2 and loss of bcl-2 expression in ductal breast carcinoma.
    Farabegoli F; Ceccarelli C; Santini D; Trerè D; Baldini N; Taffurelli M; Derenzini M
    Int J Cancer; 1996 Oct; 69(5):381-5. PubMed ID: 8900371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma.
    Lee WY; Jin YT; Tzeng CC
    Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
    Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
    J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A; Margaria E; Chiusa L
    J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.